期刊文献+

CD14^+/HLA-DR^+及纤维蛋白原在肺癌中的表达及其与预后的关系 被引量:2

Levels of CD14^+/HLA-DR^+ and fibrinogen in lung cancer and their correlations with prognosis
原文传递
导出
摘要 目的观察外周血CD14^+单核细胞中人白细胞DR抗原(CD14^+/HLA-DR^+)表达水平及纤维蛋白原(Fib)浓度变化,探讨炎性标记物检测对肺癌患者预后的评估价值。方法应用流式细胞术及免疫比浊法检测CD14^+/HLA-DR^+水平及Fib浓度,并分析其与肿瘤病理特征及无病生存期的相关性。结果肺癌外周血中CD14^+/HLA-DR^+的水平较对照组明显降低(t=-3.174,P <0.01),而Fib浓度较对照组明显升高(t=3. 46,P <0. 01);肺癌患者CD14^+/HLA-DR^+水平与Fib浓度呈负相关性(r=-0.515,P <0. 01)。患者治疗前CD14^+/HLA-DR^+水平与吸烟史、TNM分期、淋巴结转移有关(P <0. 05),Fib浓度与吸烟史、TNM分期、淋巴结转移、肿块大小、脉管癌栓及病理类型等有关(P <0. 05)。在肺癌中,CD14^+/HLA-DR^+低表达水平组和(或) Fib高浓度组的患者无病生存期明显降低(P <0. 01); Cox比例风险模型多因素分析显示,TNM分期及CD14^+/HLA-DR^+水平是影响肺癌患者无病生存期的独立预后因素(P <0. 01)。结论 CD14^+/HLA-DR^+水平及Fib浓度可作为判断肺癌恶性程度的指标; TNM分期及CD14^+/HLA-DR^+水平是影响肺癌患者无病生存期的独立预后因素。 Objective To study the detection of inflammatory markers on the prognosis of patients with lung cancer through detecting the expression of human leukocyte antigen DR(CD14^+/HLA-DR^+)in CD14^+ monocytes of peripheral blood and the changes of fibrinogen (Fib)concentrations.Methods The levels of CD14^+/HLA-DR^+ monoeytes and plasma Fib were analyzed by flow eytometry and immunoturbidimetry;and its relationship with elinicopathologic characteristics and prognostic for disease-free survival (DFS)were analyzed.Results The levels ofCD14^+/HLA-DR^+ monocytes in lung cancer patients were significantly lower than those in healthy controls (t =-3.174,P <0.01),while the Fib levels were significantly higher than those in controls (t =3.46,P <0.01);the levels of CD14^+/HLA-DR^+ monocytes was negatively correlated with Fib concentrations in patients with lung cancer (r =-0.515,P <0.01).The levels of CD14^+/HLA-DR^+ monoeytes before treatment were related with smoking history,TNM stage,and lymph node metastasis (P <0.05);Fib concentration was correlated with smoking history,TNM stage,lymph node metastasis,tumor size,vascular tumor thrombus and different histological classifications (P <0.05).The low level of CD14^+/HLA-DR^+ monocytes and/or hyperfibrinogenemia had a worse prognostic significance to patients'disease-free survival(DFS)time (P <0.01);Cox multivariate regression analysis revealed that TNM stage and CD14^+/HLA-DR^+ monocytes level were independent predictive factors for decreased DFS (P < 0.01).Conclusion The level of CD14^+/HLA-DR^+ monocytes and Fib concentration can be promising biomarkers for evaluating the progression of lung cancer;TNM stage and CD14^+/HLA-DR^+ monocytes level are independent prognositic factors affecting DFS in lung cancer patients.
作者 熊娟 张剑英 张毅敏 陶开义 徐笑红 XIONG Juan;ZHANG Jian-ying;ZHANG Yi-min;TAO Kai-yi;XU Xiao-hong(Clinical Laboratory,Xhejiang Cancer Hospital,Hangzhou,Zhejiang 310022,China)
出处 《中国卫生检验杂志》 CAS 2019年第1期54-58,共5页 Chinese Journal of Health Laboratory Technology
基金 浙江省医药卫生科技项目(2016KYA044)
关键词 肺癌 CD14 HLA—DR抗原 纤维蛋白原 预后 Lung carcinoma Cluster of differentiation 14 Human leukocyte antigen-DR Fibrinogen Prognosis
  • 相关文献

参考文献4

二级参考文献39

  • 1冷建杭,韩阳,卓广超,王克义,汪子伟,彭亮,张玉芳.类风湿关节炎患者淋巴细胞协同刺激分子和活化标志的表达及意义[J].中华检验医学杂志,2005,28(2):189-190. 被引量:2
  • 2姚咏明.免疫功能紊乱在脓毒症发病中的作用及意义[J].中国危重病急救医学,2007,19(3):138-141. 被引量:63
  • 3Angus DC, Linde- Zwirble, WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001, 29(7) :1303 -1310.
  • 4Mant TG, Borozdenkova S. Bradford DB, et al. Changes in HLA - DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers [J].Int Immunopharmacol, 2008, 8(5) :701 -107.
  • 5Monneret G, Venet F. Statins and sepsis: Do we really need to further decrease monocyte HLA - DR expression to treat septic patients [ J ]. Lancet Infect Dis, 2007, 7( 11 ) :697 -699.
  • 6Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation[J]. Cytometry, 1997, 27(1) :71 -76.
  • 7Paz A, Fiszer U, Zaborski J, et al. Phenotyping analysis of peripheral blood leukocytes in patients with muhiple sclerosis [J].Eur J Neural, 1999, 6(3) :347 -352.
  • 8Schwiebert LM, Schleimer RP, Radka SF, et al. Modulation of MHC class II expression in human cells by dexamethasone[J].Cell Immunol, 1995, 165(1) :12 -19.
  • 9Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS[J]. Crit Care Med, 1996, 24(7) :1125 -1128.
  • 10Hynninen M, Pettila V, Takkunen O. Predictive value of monocyte histocompatibility leukocyte antigen - DR expression and plasma interleukin- 4 and -10 levels in critically ill patients with sepsis [ J ]. Shock, 2003,20( 1 ) :1 -4.

共引文献8

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部